Selank vs LL-37: What's the Difference

Selank and LL-37 differ in almost everything that matters: origin, size, structure, and the research field each one gets cited in. Selank is a synthetic heptapeptide, a tuftsin analog developed in a Russian laboratory and studied mainly in neuroscience. LL-37 is a 37-amino-acid peptide the human body itself produces as part of the innate immune system, studied mainly in microbiology and immunology. The two show up in the same search largely because they both get called "research peptides," not because they resemble each other.

What Selank is

Selank is a synthetic seven-amino-acid peptide derived from tuftsin, a natural tetrapeptide of the immune system, with an added sequence that makes it more resistant to enzymatic degradation. It was developed at the Institute of Molecular Genetics in Moscow, and the research literature around it centers on the central nervous system: animal models of anxiety, cognition, and stress response.

Part of that literature also describes activity related to angiotensin-converting enzyme (ACE) and to the modulation of certain cytokines, which places Selank at an intersection of neuroscience and immunology. PeptoClinic includes Selank in its catalog of research material, with the batch documentation and technical specification available for each lot.

What LL-37 is

LL-37 is the only cathelicidin the human body produces, encoded by the CAMP gene and released from a precursor protein called hCAP-18. Unlike Selank, it is not a laboratory design — it is a molecule that circulates naturally in neutrophils, epithelial cells, and other cell types as part of the first line of defense of the innate immune system.

Its 37-amino-acid structure folds into an amphipathic alpha helix on contact with bacterial membranes, which is why the literature studies it mostly in the context of antimicrobial activity. It also appears in research models of tissue healing and immune cell chemotaxis, an area that shares some research interest with peptides like BPC-157, although the pathways described for each in the literature are distinct.

The structural differences

The most concrete difference is one of size and molecular architecture:

• Selank: 7 amino acids, linear sequence, low molecular weight. A small molecule, straightforward to synthesize chemically.
• LL-37: 37 amino acids, folding into an amphipathic alpha helix in the presence of lipid membranes. A considerably larger molecule, and its three-dimensional conformation is part of how it interacts with its biological target.

That size difference is not a minor detail — it shapes the stability of each peptide, how it is synthesized, and how its purity is documented on a certificate of analysis. A heptapeptide and a 37-residue helix do not behave the same way on an HPLC trace or a mass spectrum.

The difference in what the research literature covers

The other difference — the one that matters most to someone sourcing material for their own research program — is the field each peptide is cited in:

• Selank is cited in studies on anxiety, memory, neuroplasticity, and stress response, with a focus on the central nervous system.
• LL-37 is cited in studies on antimicrobial activity against bacteria, fungi, and some viruses, along with its role in innate immune response and tissue repair processes.

In practice, these are two separate research lines that rarely intersect. Choosing between them depends entirely on the question a laboratory is investigating, not on which one is "stronger" or "more effective" — they are molecules with different study objectives, not versions of each other.

Why they turn up together in searches

It is common for someone to search "Selank vs LL-37" because they are actually comparing two lists of peptides seen on different sites, without any real structural or functional relationship between the two. The same thing happens with other frequent comparisons in the catalog, such as Selank against Semax — there the comparison makes more sense, because both are nootropic peptides of Russian origin with a shared development history. With LL-37 that closeness doesn't exist: the only thing the two have in common is that both get sold as research material in lyophilized vials.

Documentation and purity

Any peptide used in a serious research program needs traceability: which batch it came from, which laboratory analyzed it, and what purity was reported. The standard PeptoClinic applies to the research peptides in its catalog is purity of 99% or higher by HPLC, with corresponding batch documentation available on request. The quality page explains how to read a certificate of analysis and what to check before accepting a lot.

LL-37 is not currently part of PeptoClinic's catalog. If a research program requires that specific molecule, the same documentation — a certificate of analysis with reported purity and laboratory verification — should be requested from any supplier offering it, applying the same standard that would apply to Selank or to any other catalog peptide.

Laboratory research material only

Selank, LL-37, and the other peptides mentioned in this article are described here within the frame of published scientific literature. This material is supplied strictly for Research Use Only (RUO): in vitro and laboratory research. It is not a drug, a supplement, or a food, it is not approved for human or veterinary consumption, and none of these statements have been evaluated by the FDA, ANMAT, or any equivalent authority. Anyone sourcing research material for Argentina receives, along with the quote, the customs documentation prepared specifically for that purpose — laboratory reference material.